Search Clinical Trials

589,087 trials

NCT07644507
Not Yet Recruiting
Role of Intraoperative Computed Tomography in Assessment of Spine Instability in Lumbar Degenerative Disease4th Military Clinical Hospital with Polyclinic, Poland
NCT07644078
Recruiting
Clinical Examination of Cavovarus FeetRoyal National Orthopaedic Hospital NHS Trust
NCT07646574
Not Yet Recruiting
Non-surgical Management After NIT for dMMR/MSI-H GCYong Zhou
NCT07644351
Completed
A Real-world Study of Asciminib Effectiveness in Philadelphia Positive Acute Lymphoblastic Leukemia PatientsNovartis Pharmaceuticals
NCT07643987
Completed
Diagnosis of Gestational Diabetes Based on a 50-gram Glucose ChallengeMethodist Health System
NCT07644390
Completed
Development of a Dynamic Prediction Model for Crohn's Disease-Related Intestinal Surgery Using Longitudinal Indices of Routine Blood Tests: A Single-Center Retrospective Cohort StudySixth Affiliated Hospital, Sun Yat-sen University
NCT07645638
CompletedNot Applicable
Virtual Reality Cognitive Stimulation for Alzheimer'sUniversidad de Burgos
NCT07646067
Not Yet RecruitingNot Applicable
Closed Loop Glucose Control in a Simulated ICU SettingEmory University
NCT07645144
Enrolling By InvitationNot Applicable
FES-assisted Gait Training for Incomplete Spinal Cord InjuryStichting Reade
NCT07645976
Completed
Home Environmental Risks and Caregiver AwarenessMarmara University Pendik Training and Research Hospital
NCT07644611
Not Yet Recruiting
Sleep, Mental Fatigue, and Performance in StudentsL.U.de.S. Sagl
NCT07646171
Recruiting
EVERST- Everolimus After Alpelisib in Women With Hormone Receptor-positive (HR+) Metastatic Breast Cancer (MBC)Tel-Aviv Sourasky Medical Center
NCT07644104
Not Yet RecruitingNot Applicable
Efficacy and Safety of the Visual Bronchial Blocker for Lung Isolation SurgeryZhejiang University
NCT07645469
Not Yet RecruitingPhase 1
FH-WT1-E50 TCR T Cells With Azacitidine for the Treatment of Minimal Residual Disease Positive Acute Myeloid LeukemiaFred Hutchinson Cancer Center
NCT07644754
Not Yet RecruitingNot Applicable
Patients With Metastasized Prostate Cancer Whose Prostate-specific Antigen-level (PSA) Remains >0,2 ng/ml After Six Months of Dual Antihormonal Therapy Will Receive Radiotherapy to the Prostate and Radiotherapy to Refractory MetastasesLudwig-Maximilians - University of Munich
NCT07646158
Not Yet RecruitingPhase 4
Alignment Techniques in TKA RCTJacob M. Elkins
NCT07644897
RecruitingPhase 2
Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced MelanomaSun Yat-sen University
NCT07644325
RecruitingNot Applicable
Concordance for Transthyretin Amyloidosis Between Synovial Biopsy and Anterior Carpal Ligament BiopsyClinique Saint Jean, France
NCT07645079
Not Yet RecruitingNot Applicable
Automated Insulin Delivery Versus Daily Injections for Hospital Diabetes CareSteno Diabetes Center Copenhagen
NCT07645326
Not Yet RecruitingPhase 2
RISK-ADAPT Protocol in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)Georgetown University